JP2022520907A5 - - Google Patents

Info

Publication number
JP2022520907A5
JP2022520907A5 JP2021571643A JP2021571643A JP2022520907A5 JP 2022520907 A5 JP2022520907 A5 JP 2022520907A5 JP 2021571643 A JP2021571643 A JP 2021571643A JP 2021571643 A JP2021571643 A JP 2021571643A JP 2022520907 A5 JP2022520907 A5 JP 2022520907A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
nhc
och
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571643A
Other languages
English (en)
Japanese (ja)
Other versions
JP7746165B2 (ja
JP2022520907A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/018890 external-priority patent/WO2020172324A1/en
Publication of JP2022520907A publication Critical patent/JP2022520907A/ja
Publication of JP2022520907A5 publication Critical patent/JP2022520907A5/ja
Priority to JP2025061013A priority Critical patent/JP2025118609A/ja
Application granted granted Critical
Publication of JP7746165B2 publication Critical patent/JP7746165B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021571643A 2019-02-19 2020-02-19 Nurr1受容体調節因子 Active JP7746165B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025061013A JP2025118609A (ja) 2019-02-19 2025-04-02 Nurr1受容体調節因子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962807642P 2019-02-19 2019-02-19
US62/807,642 2019-02-19
PCT/US2020/018890 WO2020172324A1 (en) 2019-02-19 2020-02-19 Nurr1 receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025061013A Division JP2025118609A (ja) 2019-02-19 2025-04-02 Nurr1受容体調節因子

Publications (3)

Publication Number Publication Date
JP2022520907A JP2022520907A (ja) 2022-04-01
JP2022520907A5 true JP2022520907A5 (https=) 2023-02-28
JP7746165B2 JP7746165B2 (ja) 2025-09-30

Family

ID=72143886

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021571643A Active JP7746165B2 (ja) 2019-02-19 2020-02-19 Nurr1受容体調節因子
JP2025061013A Pending JP2025118609A (ja) 2019-02-19 2025-04-02 Nurr1受容体調節因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025061013A Pending JP2025118609A (ja) 2019-02-19 2025-04-02 Nurr1受容体調節因子

Country Status (7)

Country Link
US (1) US20230063230A1 (https=)
EP (1) EP3927330A4 (https=)
JP (2) JP7746165B2 (https=)
CN (2) CN120097859A (https=)
AU (2) AU2020226633C1 (https=)
CA (1) CA3130269A1 (https=)
WO (1) WO2020172324A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114728909A (zh) * 2019-09-25 2022-07-08 韩国原子力医学院 含有新型三氟甲基苯基吡唑衍生物作为活性成分用于预防或治疗癌症的组合物
IL319572A (en) 2022-09-26 2025-05-01 Alterome Therapeutics Inc AKT1 modulators
US20240247001A1 (en) 2022-12-16 2024-07-25 Astrazeneca Ab 2,6,9-trisubstituted purines

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5714505A (en) * 1980-07-01 1982-01-25 Ube Ind Ltd Herbicide
GB8702613D0 (en) * 1987-02-05 1987-03-11 Ici Plc Compositions
DE10206723A1 (de) * 2002-02-18 2003-09-04 Ulrich Schraermeyer Therapie von Erkrankungen des Auges und des Zentralen Nervensystems
TW200505452A (en) * 2003-06-17 2005-02-16 Astrazeneca Ab Chemical compounds
AU2004285053B2 (en) * 2003-10-28 2010-10-21 Vertex Pharmaceuticals, Incorporated Benzimidazoles useful as modulators of ion channels
SE0401653D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
WO2007120012A1 (en) * 2006-04-19 2007-10-25 Amorepacific Corporation Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
WO2009047240A1 (en) * 2007-10-09 2009-04-16 Smithkline Beecham Corporation Indole derivatives useful as ppar activators
FR2925906B1 (fr) * 2008-01-02 2010-08-20 Sanofi Aventis COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
HRP20151367T1 (hr) * 2008-05-13 2016-01-29 Yale University Kimerne male molekule za pojaäśanje odgovora protutijela na stanice raka
JP2012529518A (ja) * 2009-06-09 2012-11-22 アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー ヘッジホッグシグナル伝達のピリジル−トリアジン阻害剤
FR2955110A1 (fr) * 2010-01-08 2011-07-15 Fournier Lab Sa Nouveaux derives de type pyrrolopyridine benzoique
US9034916B2 (en) * 2011-04-06 2015-05-19 Korea Research Institute Of Bioscience And Biotechnology Pharmaceutical composition for the prevention or treatment of a neurodegenerative disease, comprising a Daphne genkwa extract or a compound isolated therefrom
WO2015159175A1 (en) * 2014-04-15 2015-10-22 Pfizer Inc. Tropomyosin-related kinase inhibitors containing both a 1h-pyrazole and a pyrimidine moiety
WO2015170218A1 (en) * 2014-05-07 2015-11-12 Pfizer Inc. Tropomyosin-related kinase inhibitors
WO2016201354A1 (en) * 2015-06-11 2016-12-15 Globavir Biosciences, Inc. Methods and compositions for treating cancer
LU92852B1 (en) * 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease
JP2018537502A (ja) * 2015-12-16 2018-12-20 サウザーン リサーチ インスチチュート ピロロピリミジン化合物、キナーゼlrrk2阻害剤としての使用、及びその調製方法
US20190151289A1 (en) * 2016-05-13 2019-05-23 Yale University Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) Histone Demethylase
AU2017279027A1 (en) * 2016-06-08 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Chemical Compounds
CN106518793B (zh) 2016-10-25 2018-11-27 中国农业大学 一种含1,2,3-三唑环的酰胺类化合物及其制备方法与应用
CN106967047A (zh) 2017-03-29 2017-07-21 山东大学 一种取代二芳基烟酰胺类衍生物及其制备方法与应用
EP3612526A2 (en) * 2017-04-20 2020-02-26 The Regents of the University of California K-ras modulators
US11872236B2 (en) * 2018-04-05 2024-01-16 Calasia Pharmaceuticals, Inc. Pharmacological agents for treating ocular diseases

Similar Documents

Publication Publication Date Title
JP2022520907A5 (https=)
JP2020517600A5 (https=)
EP3288558B1 (en) Combinations of inhibitors of irak4 with inhibitors of btk
RU2468021C2 (ru) Гетероциклические соединения и их применение
JP2020514254A5 (https=)
JP2024041959A5 (https=)
JP2017528498A5 (https=)
JP2019507793A5 (https=)
US20160129027A1 (en) Cleavable drug conjugates, compositions thereof and methods of use
JP2012502964A5 (https=)
PT1663244E (pt) Derivados de ptiridina para o tratamento de doenças relacionadas com o tnf-alfa
JP2010523562A5 (https=)
JP2021502387A5 (https=)
JP2025505994A5 (https=)
JP2024505558A5 (https=)
JP2008308501A (ja) 抗血管形成剤としての新規なフタルイミドミミックスの合成および評価
TW201708193A (zh) 突變之異檸檬酸脫氫酶idh1 r132h之抑制劑
EP2386553A1 (en) Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
JP2018538354A5 (https=)
CN118019539A (zh) 用于降解BTK并具有增强的IMiD活性的双官能化合物
JP2001510843A5 (https=)
JP2021505541A5 (https=)
JP2023538524A5 (https=)
JPWO2023163227A5 (https=)
JP2025183238A5 (https=)